Full Text View
Tabular View
No Study Results Posted
Related Studies
Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate
This study has been completed.
Study NCT00262600   Information provided by Boehringer Ingelheim Pharmaceuticals
First Received: December 6, 2005   Last Updated: May 25, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Atrial Fibrillation
Cerebrovascular Accident
Additional conditions recognized in this trial
Cerebral Infarction
Stroke
More general conditions related to this trial
Arrhythmias, Cardiac
Brain Diseases
Brain Infarction
Brain Ischemia
Cardiovascular Diseases
Central Nervous System Diseases
Cerebrovascular Disorders
Heart Diseases
Nervous System Diseases
Pathologic Processes
Vascular Diseases
Interventions listed in this trial
Dabigatran etex
Warfarin
Additional drug interventions recognized in this trial
Anticoagulants
More general drug interventions related to this trial
Hematologic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Boehringer Ingelheim Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services